Impact Factor
3.87
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
4.87
1,197 total citations
h5-index
45
h5 depth signal
Cited share
69.1%
177 of 256
Total citations
1,197
Citation footprint
Metric signal
5.58
External metric anchor
Self-citation
1.0%
12 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
587
China
261
United Kingdom
110
Canada
94
Germany
93
Citing Fields of Research
Stem Cell Biology
1,314
Hematology
199
Noncoding RNA
97
Musculoskeletal Disorders
93
Cell Differentiation & Development
85
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
2,308
Articles tracked across the journal lifetime
Indexed publication set
256
177 cited publications
Last 12 months
97
9.7 publications/month
Open access share
97.9%
95 OA publications in the last year
Leading citing country
United States
587 citing publications
Leading citing field
Stem Cell Biology
1,314 citing publications
Latest tracked publication
16 October 2026
10 recent records available
Coverage & Indexing History
v1n1, Jan. 2012-
v1n1, Jan. 2012-
Active Coverage
Research Focus & Classification
Indexed Subjects
Stem Cell Biology
Broad Categories
Cell Biology
Therapeutics
Stem Cell Biology
Hematology
Noncoding RNA
Ophthalmology
Musculoskeletal Disorders
MeSH Descriptors
Stem Cells
Translational Research, Biomedical.
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1093/stcltm/szag086
Open DOI
Human umbilical cord mesenchymal stem cells alleviate brain injury and promote neuroregeneration via BDNF/TrkB/CREB/PI3K-Akt pathway in preterm rats with intraventricular hemorrhage
Objective: To explore the neuroprotective effect and molecular mechanism of human umbilical cord mesenchymal stem cells (hUC-MSCs) in preterm rats with intraventricular hemorrhage (IVH), and provide experimental basis for clinical treatm...
02
DOI 10.1093/stcltm/szag076
Open DOI
Haploidentical HSCT vs immunosuppressive therapy for severe aplastic anemia in patients aged 40-65 years: a retrospective comparative study
Severe aplastic anemia (SAA) is a life-threatening hematological disorder, and the optimal treatment for patients aged ≥40 years remains controversial. This retrospective study aims to conduct a comparative analysis of the efficacy of im...
03
DOI 10.1093/stcltm/szag078
Open DOI
Kidney organoids as a platform to study plasminogen-induced injury and uPA-based therapies
Urinary plasminogen has been implicated in the progression of proteinuric kidney diseases, yet its direct role in mediating injury along the nephron remains incompletely understood. Experimental models commonly used to study plasminogen-...
04
DOI 10.1093/stcltm/szag073
Open DOI
JAG1 c.1615C > T mutation impairs bile duct regeneration but not differentiation in hepatic organoids derived from a patient with Alagille syndrome
Objective: Alagille syndrome (ALGS) is an autosomal dominant disorder caused primarily by mutations in JAG1. Intrahepatic bile duct paucity is the most consistently reported feature of ALGS; however, the mechanisms associated with biliar...
05
DOI 10.1093/stcltm/szag082
Open DOI
Single-cell transcriptomics reveals critical role of CD74 in bone marrow–derived mesenchymal stem cells
Background: Human bone marrow aspirates have been widely used for skeletal tissue regeneration. However, clinical outcomes of the tissue repair after transplantation are variable. Methods: In this study, we analyzed the molecular signatu...
06
DOI 10.1093/stcltm/szag083
Open DOI
Effect of intrathecal injection of mesenchymal stem cell-neural progenitors on cerebrospinal fluid biomarkers in progressive multiple sclerosis
Mesenchymal stem cell-neural progenitors (MSC-NP) are a bone marrow mesenchymal stem cell–derived population of cells with trophic and immunomodulatory properties with therapeutic potential in multiple sclerosis (MS). Early phase clinica...
07
DOI 10.1093/stcltm/szag061
Open DOI
Fate of long-term culture on hepatocyte-like cells generated from human adipose–derived mesenchymal stem cells
Background: We previously established a 21-day protocol to generate hepatocyte-like cells (HLCs) from adipose-derived stem cells and are conducting preclinical studies toward their clinical application in liver failure. This study examin...
08
DOI 10.1093/stcltm/szag081
Open DOI
Intranasal stem cell treatment ameliorates neuroinflammation and myelin aberrations in fetal growth-restricted rat pups
Fetal growth restriction (FGR), a condition in which a fetus fails to reach its full growth potential, affects approximately 30 million infants worldwide each year and increases the risk of long-term neurodevelopmental deficits. Currentl...
09
DOI 10.1093/stcltm/szag080
Open DOI
Why retracted articles can have an influential afterlife—and what to do about it
Retractions of published journal articles are an increasingly common means by which the research community ensures the quality and integrity of publications and addresses research misconduct missed during pre-publication peer review. Ret...
10
DOI 10.1093/stcltm/szag070
Open DOI
Reduced mechanical shear is associated with early cortical differentiation and GDNF-GFRA1/RET signalling in human brain organoids
Early cortical differentiation in human brain organoids is a critical step of corticogenesis, but remains poorly coordinated under conventional culture conditions. In a standard orbital shaker system, mechanical shear and variability in ...
Bibliographical & Catalog Notes
Some articles in v. 2012 published electronically in 2011.
Also issued online.